{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:16:23Z","timestamp":1778868983750,"version":"3.51.4"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["2018-12366399"],"award-info":[{"award-number":["2018-12366399"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GGP19201"],"award-info":[{"award-number":["GGP19201"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2018-0253"],"award-info":[{"award-number":["2018-0253"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["667421"],"award-info":[{"award-number":["667421"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005699","name":"Universit\u00e0 degli Studi del Piemonte Orientale","doi-asserted-by":"publisher","award":["FAR 2017"],"award-info":[{"award-number":["FAR 2017"]}],"id":[{"id":"10.13039\/501100005699","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.omtm.2021.10.015","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T04:27:42Z","timestamp":1635913662000},"page":"551-566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5738-213X","authenticated-orcid":false,"given":"Cristina","family":"Olgasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9704-0647","authenticated-orcid":false,"given":"Chiara","family":"Borsotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Merlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6370-449X","authenticated-orcid":false,"given":"Patrick","family":"Bittorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeolu Badi","family":"Adewoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Wragg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9568-7241","authenticated-orcid":false,"given":"Kelcey","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-3384","authenticated-orcid":false,"given":"Andrea","family":"Calabria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6378-125X","authenticated-orcid":false,"given":"Fabrizio","family":"Benedicenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5003-831X","authenticated-orcid":false,"given":"Alessia","family":"Cucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Borchiellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berardino","family":"Pollio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1771-6067","authenticated-orcid":false,"given":"Eugenio","family":"Montini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delfina M.","family":"Mazzuca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Zierau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Stolzing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip.M.","family":"Toleikis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joris","family":"Braspenning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9780-300X","authenticated-orcid":false,"given":"Antonia","family":"Follenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2021.10.015_bib1","series-title":"Lancet","first-page":"1801","article-title":"Haemophilias A and B","author":"Bolton-Maggs","year":"2003"},{"key":"10.1016\/j.omtm.2021.10.015_bib2","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1056\/NEJM200106073442301","article-title":"Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A","volume":"344","author":"Roth","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2021.10.015_bib3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/hae.13251","article-title":"PK-guided personalized prophylaxis with Nuwiq\u00ae (human-cl rhFVIII) in adults with severe haemophilia A","volume":"23","author":"Lissitchkov","year":"2017","journal-title":"Haemophilia"},{"key":"10.1016\/j.omtm.2021.10.015_bib4","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/hae.12952","article-title":"Efficacy and safety of BAY 81-8973, a full-length recombinant factor VIII: results from the LEOPOLD I trial","volume":"22","author":"Saxena","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.omtm.2021.10.015_bib5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood-2016-01-687434","article-title":"Efficacy and safety of rVIII-singlechain: results of a phase 1\/3 multicenter clinical trial in severe hemophilia A","volume":"128","author":"Mahlangu","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.10.015_bib6","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1111\/hae.13617","article-title":"Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: final results from the guardian 2 extension trial","volume":"24","author":"Lentz","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.omtm.2021.10.015_bib7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/hae.13438","article-title":"Defining extended half-life rFVIII\u2014a critical review of the evidence","volume":"24","author":"Mahlangu","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.omtm.2021.10.015_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/blood-2013-10-529974","article-title":"Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A","volume":"123","author":"Mahlangu","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.10.015_bib9","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood-2015-03-630897","article-title":"Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A","volume":"126","author":"Konkle","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.10.015_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/bjh.16377","article-title":"Advances in knowledge of inhibitor formation in severe haemophilia A","volume":"189","author":"Cormier","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omtm.2021.10.015_bib11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1365-2516.2002.00626.x","article-title":"Inhibitors: resolving diagnostic and therapeutic dilemmas","volume":"8","author":"Dimichele","year":"2002","journal-title":"Haemophilia"},{"key":"10.1016\/j.omtm.2021.10.015_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/blood.2019000658","article-title":"Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A","volume":"134","author":"Van Den Berg","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.10.015_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1703068","article-title":"Emicizumab prophylaxis in hemophilia A with inhibitors","volume":"377","author":"Oldenburg","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2021.10.015_bib14","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/S2352-3026(19)30054-7","article-title":"Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4\u00a0weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study","volume":"6","author":"Pipe","year":"2019","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.omtm.2021.10.015_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/hae.13877","article-title":"Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors","volume":"26","author":"Ebbert","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.omtm.2021.10.015_bib16","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1182\/blood-2019-126659","article-title":"Severe bleeding events in hemophilia A patients receiving emicizumab prophylaxis","volume":"134","author":"Zimowski","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.10.015_bib17","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/317726a0","article-title":"Distribution of factor VIII MRNA and antigen in human liver and other tissues","volume":"317","author":"Wion","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2021.10.015_bib18","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.transproceed.2006.03.020","article-title":"Ten-year experience with living related donated splenic transplantation for the treatment of hemophilia","volume":"38","author":"Jiang","year":"2006","journal-title":"A.\u00a0Transpl. Proc."},{"key":"10.1016\/j.omtm.2021.10.015_bib19","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1055\/s-0037-1616143","article-title":"Tissue distribution of factor VIII gene expression in\u00a0vivo\u2014a closer look","volume":"86","author":"Hollestelle","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.omtm.2021.10.015_bib20","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1111\/j.1538-7836.2005.01543.x","article-title":"Extra-hepatic factor VIII expression in porcine fulminant hepatic failure","volume":"3","author":"Hollestelle","year":"2005","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.omtm.2021.10.015_bib21","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1182\/blood-2011-07-367680","article-title":"Role of bone marrow transplantation for correcting hemophilia A in mice","volume":"119","author":"Follenzi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.10.015_bib22","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3324\/haematol.2014.123117","article-title":"Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A","volume":"100","author":"Zanolini","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.omtm.2021.10.015_bib23","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1538-7836.2005.01508.x","article-title":"Transplantation of endothelial cells corrects the phenotype in hemophilia A mice","volume":"3","author":"Kumaran","year":"2005","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.omtm.2021.10.015_bib24","doi-asserted-by":"crossref","first-page":"e77255","DOI":"10.1371\/journal.pone.0077255","article-title":"Production of factor VIII by human liver sinusoidal endothelial cells transplanted in immunodeficient uPA mice","volume":"8","author":"Fomin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2021.10.015_bib25","first-page":"935","article-title":"Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A mice","volume":"118","author":"Follenzi","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2021.10.015_bib26","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3727\/096368912X657594","article-title":"Human liver endothelial cells, but not macrovascular or microvascular endothelial cells, engraft in the mouse liver","volume":"22","author":"Filali","year":"2013","journal-title":"Cell Transpl."},{"key":"10.1016\/j.omtm.2021.10.015_bib27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.transci.2019.08.012","article-title":"Gene therapy for hemophilia: progress to date and challenges moving forward","volume":"58","author":"Gollomp","year":"2019","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.omtm.2021.10.015_bib28","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/hae.13816","article-title":"Clinical advances in gene therapy updates on clinical trials of gene therapy in haemophilia","volume":"25","author":"Peyvandi","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.omtm.2021.10.015_bib29","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3389\/fimmu.2020.00618","article-title":"Translational potential of immune tolerance induction by AAV liver-directed factor VIII gene therapy for hemophilia A","volume":"11","author":"Samelson-Jones","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2021.10.015_bib30","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1182\/bloodadvances.2018027979","article-title":"FVIII expression by its native promoter sustains long-term correction avoiding immune response in hemophilic mice","volume":"3","author":"Merlin","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtm.2021.10.015_bib31","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.stemcr.2018.10.012","article-title":"Patient-specific iPSC-derived endothelial cells provide long-term phenotypic correction of hemophilia A","volume":"11","author":"Olgasi","year":"2018","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.omtm.2021.10.015_bib32","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1186\/s13287-019-1138-8","article-title":"Potential long-term treatment of hemophilia A by neonatal co-transplantation of cord blood-derived endothelial colony-forming cells and placental mesenchymal stromal cells","volume":"10","author":"Gao","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.omtm.2021.10.015_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.stem.2015.07.001","article-title":"Functional correction of large factor VIII gene chromosomal inversions in hemophilia A patient-derived iPSCs using CRISPR-cas9","volume":"17","author":"Park","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2021.10.015_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083280","article-title":"A novel cell-sheet technology that achieves durable factor VIII delivery in a mouse model of hemophilia A","volume":"8","author":"Tatsumi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2021.10.015_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1172\/JCI8071","article-title":"Origins of circulating endothelial cells and endothelial outgrowth from blood","volume":"105","author":"Lin","year":"2000","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2021.10.015_bib36","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1182\/blood-2006-08-043471","article-title":"Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem\/progenitor cell principals","author":"Yoder","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.10.015_bib37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.biomaterials.2012.09.046","article-title":"The blood and vascular cell compatibility of heparin-modified ePTFE vascular grafts","volume":"34","author":"Hoshi","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtm.2021.10.015_bib38","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1182\/blood-2006-12-062471","article-title":"In\u00a0vivo vasculogenic potential of human blood-derived endothelial progenitor cells","volume":"109","author":"Melero-Martin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.10.015_bib39","doi-asserted-by":"crossref","first-page":"8356","DOI":"10.1016\/j.biomaterials.2011.07.066","article-title":"Use of autologous blood-derived endothelial progenitor cells at point-of-care to protect against implant thrombosis in a large animal model","volume":"32","author":"Jantzen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtm.2021.10.015_bib40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1538-7836.2011.04554.x","article-title":"Therapeutic effect of fucoidan-stimulated endothelial colony-forming cells in peripheral ischemia","volume":"10","author":"Sarlon","year":"2012","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.omtm.2021.10.015_bib41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1182\/blood.V99.2.457","article-title":"Use of blood outgrowth endothelial cells for gene therapy for hemophilia A","volume":"99","author":"Lin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.10.015_bib42","series-title":"Reflection Paper on Classification of Advanced Therapy Medicinal Products","author":"Medicines Agency, E.","year":"2015"},{"key":"10.1016\/j.omtm.2021.10.015_bib43","series-title":"Guideline on Quality, Non-clinical and Clinical Aspects of Medicinal Products Containing Genetically Modified Cells","author":"Medicines Agency, E.","year":"2020"},{"key":"10.1016\/j.omtm.2021.10.015_bib44","series-title":"Guideline on the Non-clinical Studies Required before\u00a0First Clinical Use of Gene Therapy Medicinal Products","author":"Medicines Agency, E.","year":"2008"},{"key":"10.1016\/j.omtm.2021.10.015_bib45","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1097\/TP.0000000000000864","article-title":"Diabetes is reversed in a murine model by marginal mass syngeneic islet transplantation using a subcutaneous cell pouch device","volume":"99","author":"Pepper","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.omtm.2021.10.015_bib46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/gt.2010.163","article-title":"Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction","volume":"18","author":"Charrier","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2021.10.015_bib47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/hgtb.2017.078","article-title":"Development of the first World Health Organization lentiviral vector standard: toward the production control and standardization of lentivirus-based gene therapy products","volume":"28","author":"Zhao","year":"2017","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2021.10.015_bib48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11010-006-9359-4","article-title":"Gene expression profiles of endothelial progenitor cells by oligonucleotide microarray analysis","volume":"298","author":"Furuhata","year":"2007","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.omtm.2021.10.015_bib49","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1593\/neo.07643","article-title":"Differential gene expression of primary cultured lymphatic and blood vascular endothelial cells","volume":"9","author":"Nelson","year":"2007","journal-title":"Neoplasia"},{"key":"10.1016\/j.omtm.2021.10.015_bib50","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1634\/stemcells.2006-0699","article-title":"Ex\u00a0vivo gene therapy for hemophilia A that enhances safe delivery and sustained in\u00a0vivo factor VIII expression from lentivirally engineered endothelial progenitors","volume":"25","author":"Matsui","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.omtm.2021.10.015_bib51","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3324\/haematol.13427","article-title":"Storage and regulated secretion of factor VIII in blood outgrowth endothelial cells","volume":"94","author":"Biggelaar","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.omtm.2021.10.015_bib52","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1242\/jcs.037507","article-title":"Novel functions of the CD34 family","volume":"121","author":"Nielsen","year":"2008","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.omtm.2021.10.015_bib53","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ymthe.2006.03.012","article-title":"HIV integration site selection: targeting in macrophages and the effects of different routes of viral entry","volume":"14","author":"Barr","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.10.015_bib54","first-page":"341","article-title":"Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome","volume":"80","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtm.2021.10.015_bib55","first-page":"341","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"80","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtm.2021.10.015_bib56","doi-asserted-by":"crossref","first-page":"10209","DOI":"10.1093\/nar\/gku769","article-title":"Molecular mechanisms of retroviral integration site selection","volume":"42","author":"Kvaratskhelia","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2021.10.015_bib57","unstructured":"Study to Evaluate the Efficacy and Safety of PF-07055480 \/ Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults (AFFINE) - ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04370054."},{"key":"10.1016\/j.omtm.2021.10.015_bib58","unstructured":"Gene therapy for haemophilia A - full text view - ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03001830."},{"key":"10.1016\/j.omtm.2021.10.015_bib59","unstructured":"A gene transfer study for hemophilia A - full text view - ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03003533."},{"key":"10.1016\/j.omtm.2021.10.015_bib60","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jth.12412","article-title":"Human liver sinusoidal endothelial cells but not hepatocytes contain factor VIII","volume":"12","author":"Shahani","year":"2014","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.omtm.2021.10.015_bib61","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1182\/blood-2014-02-554501","article-title":"Murine coagulation factor VIII is synthesized in endothelial cells","volume":"123","author":"Everett","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.10.015_bib62","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1182\/blood-2014-02-555151","article-title":"A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII","volume":"123","author":"Fahs","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.10.015_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2516.2009.02005.x","article-title":"Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance","volume":"16","author":"Terraube","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.omtm.2021.10.015_bib64","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1182\/blood-2013-12-545780","article-title":"Omental implantation of BOECs in hemophilia dogs results in circulating FVIII antigen and a complex immune response","volume":"123","author":"Ozelo","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.10.015_bib65","article-title":"Generation and culture of blood outgrowth endothelial cells from human peripheral blood","volume":"2015","author":"Ormiston","year":"2015","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.omtm.2021.10.015_bib66","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1172\/JCI93649","article-title":"Blood endothelial cells: utility from ambiguity","volume":"127","author":"Hebbel","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2021.10.015_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-94307-0","article-title":"Characterization and visualization of murine coagulation factor VIII-producing cells in\u00a0vivo","volume":"11","author":"Hayakawa","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2021.10.015_bib68","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.ymthe.2017.04.029","article-title":"A novel platform for immune tolerance induction in hemophilia A mice","volume":"25","author":"Merlin","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.10.015_bib69","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.amjsurg.2011.02.009","article-title":"A novel technique for the transplantation of pancreatic islets within a vascularized device into the greater omentum to achieve insulin independence","volume":"203","author":"Kriz","year":"2012","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.omtm.2021.10.015_bib70","unstructured":"A. Safety, tolerability and efficacy study of Sernova\u2019s Cell PouchTM for clinical islet transplantation - full text view - ClinicalTrials.Gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03513939."},{"key":"10.1016\/j.omtm.2021.10.015_bib71","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/01.ATV.0000114236.77009.06","article-title":"Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis","volume":"24","author":"Hur","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.omtm.2021.10.015_bib72","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jbm.a.33040","article-title":"Engineering an antiplatelet adhesion layer on an electrospun scaffold using porcine endothelial progenitor cells","volume":"97 A","author":"Zhang","year":"2011","journal-title":"J.\u00a0Biomed. Mater. Res. - Part A."},{"key":"10.1016\/j.omtm.2021.10.015_bib73","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.omtm.2020.05.029","article-title":"Regulatory-compliant validation of a highly sensitive qPCR for biodistribution assessment of hemophilia A patient cells","volume":"18","author":"Bittorf","year":"2020","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2021.10.015_bib74","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1089\/ten.tec.2009.0492","article-title":"Enrichment of outgrowth endothelial cells in high and low colony-forming cultures from peripheral blood progenitors","volume":"16","author":"Kolbe","year":"2010","journal-title":"Tissue Eng. - Part C Methods"},{"key":"10.1016\/j.omtm.2021.10.015_bib75","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1182\/blood-2010-10-312926","article-title":"The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones","volume":"117","author":"Gillet","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.10.015_bib76","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/gm568","article-title":"Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites","volume":"6","author":"Firouzi","year":"2014","journal-title":"Genome Med."},{"key":"10.1016\/j.omtm.2021.10.015_bib77","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","article-title":"Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial","volume":"388","author":"Sessa","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2021.10.015_bib78","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-017-1937-9","article-title":"VISPA2: a scalable pipeline for high-throughput identification and annotation of vector integration sites","volume":"18","author":"Spinozzi","year":"2017","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.omtm.2021.10.015_bib79","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/bioinformatics\/bts004","article-title":"Estimating abundances of retroviral insertion sites from DNA fragment length data","volume":"28","author":"Berry","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtm.2021.10.015_bib80","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1182\/blood-2010-09-306761","article-title":"Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection","volume":"117","author":"Biffi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.10.015_bib81","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.1630","article-title":"GREAT improves functional interpretation of cis-regulatory regions","volume":"28","author":"McLean","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2021.10.015_bib82","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5493\/wjem.v2.i2.30","article-title":"Standardizing a simpler, more sensitive and accurate tail bleeding assay in mice","volume":"2","author":"Liu","year":"2012","journal-title":"World J. Exp. Med."},{"key":"10.1016\/j.omtm.2021.10.015_bib83","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2004-08-2990","article-title":"Factor IX variants improve gene therapy efficacy for hemophilia B","volume":"105","author":"Schuettrumpf","year":"2005","journal-title":"Blood"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121001728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121001728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:53:01Z","timestamp":1778867581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050121001728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":83,"alternative-id":["S2329050121001728"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2021.10.015","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2021.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}]}}